WebenPharma
PrivateLast Round
Angel
Jan 28, 2022
Company Overview
WebenPharma is a biopharmaceutical company that focuses on the discovery, development, and commercialization of targeted small molecule drugs to treat cancer patients.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
WebenPharma Comparables
Compare WebenPharma with similar companies based on industry and business-model similarity.
WebenPharma Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Angel | Jan 28, 2022 | ||||
| Angel | Jan 28, 2019 |
WebenPharma Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tailong Investment | Angel |
| Tigeryeah Capital | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 28, 2019
Completed an angel funding round.
WebenPharma Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about WebenPharma's valuation, stock price, and market status.